Official account. Marseille Immunology Biocluster, where the future of Immunology comes to life.
Marseille
Joined October 2024
- Tweets128
- Following91
- Followers26
- Likes31
🧬 ID3 emerges as a key regulator of stem-like T cells, essential for durable immunity against cancer and chronic infections. A major breakthrough in understanding and enhancing immunotherapeutic strategies. 👉science.org/doi/10.1126/scii…
Our B & T cells remember past threats 🦠. Now, Stanford’s AI Mal-ID decodes these immune "fingerprints" to improve autoimmune disease diagnosis! 🔍 med.stanford.edu/news/all-ne…
Marseille Immunology Biocluster retweeted
#Mitochondrial damage can contribute to #InflammatoryBowelDisease, catch up with the literature with this review online now:
mucosalimmunology.org/articl…
Marseille Immunology Biocluster retweeted
A new Science #Immunology study reveals that #BreakoutLesions in patients with #MultipleMyeloma contain hotspots of tumor-immune cell co-evolution, which could inform future therapeutics. scim.ag/4hMrLHs
How does the gut orchestrate its defense? 🏰 Researchers tracked TRM cells in action: strategic positioning and rapid response, a model for future targeted therapies. Learn more 👉lji.org/news-events/news/pos… #Immunology
Marseille Immunology Biocluster retweeted
A new @unibirmingham trial showed promising results for treating patients with #IBD and autoimmune liver disease by utilising a common antibiotic to treat infective diarrhoea, with 80% achieving clinical remission.
Full article now online: bit.ly/4aSoGn2
ALT A close-up image of someone holding three white tablets in their hand.
Marseille Immunology Biocluster retweeted
Type 1 diabetes is rising. Access key resources to:
• Improve early screening
• Provide mental health support
• Reduce misdiagnosis
🔗 Learn more: bit.ly/48ZlwwS
#DiabetesCare #Type1Diabetes #HealthCare
Marseille Immunology Biocluster retweeted
In the latest #SciencePodcast🎙️, Dan Kaplan, a professor in the departments of immunology and dermatology, talks about why it sometimes pays to scratch that itch.
🎧 Listen here: scim.ag/4aFVtf8
🧬 Dendritic cells (cDCs) activate immunity, but their maturation relies on cholesterol. AXL, a regulatory enzyme, blocks this process by restricting cholesterol transport. Inhibiting it could enhance anti-cancer responses. 👉 nature.com/articles/s41590-0…
Marseille Immunology Biocluster retweeted
Kidney immunology from pathophysiology to clinical translation bit.ly/3PWYiPi
Persistent inflammation without a diagnosis? A study highlights the challenges of SAIDs and offers solutions: genetic testing, empirical trials of therapy, and close follow-up and reassurance to manage uncertainty around diagnosis. 🏥 @touchimmunology 🔗touchimmunology.com/rheumato…
Marseille Immunology Biocluster retweeted
Researchers have demonstrated that #CARTcells can transfer tumor-specific receptors to T cells in mice via #trogocytosis, endowing recipient cells with antitumor immunity. @UU_University
Read more in Science #Immunology: scim.ag/3CwCE1c
Senior microbiome enhances immunotherapy! 🧬 In people over 60, specific gut bacteria stimulate T cells, boosting the effectiveness of cancer treatments. Toward more powerful immunotherapy? 🔗 biocodexmicrobiotainstitute.…
Marseille Immunology Biocluster retweeted
Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer [Jul 26, 2022] @YinjieGao et al. Cancer Immunology, Immunotherapy link.springer.com/article/10… #ImmunoOnc #lcsm #PrecisionMedicine
Marseille Immunology Biocluster retweeted
A Science #Immunology study from last year describes an antibody-based alternative treatment for B cell non-Hodgkin #lymphoma that boosts #NaturalKillerCell antitumor activity in preclinical models without causing serious toxicities. bit.ly/4fM7bpT #WorldCancerDay
🚨 26% relapse after kidney transplant! A study on 137 patients confirms that anti-PLA2R1 antibodies are a key risk factor for relapse. Targeted monitoring is essential 🩺
👏Kudos to Dr. Cremoni and the @CHUdeNice team!
🔗 kireports.org/article/S2468-…
Slowing Type 1 Diabetes before insulin dependence is now possible!🔬By modulating the activity of T cells, beta cells killers, an anti-CD3 antibody protects them and delays the need for insulin. A groundbreaking breakthrough from @sanofi🔗sanofi.com/fr/magazine/notre…
Why does immunotherapy work for some but not others? 🤔 New research highlights the critical role of the immune microenvironment in #AML treatment. 🧪
Full study here: ma-clinique.fr/lenvironnemen…
At @queensu 🇨🇦, Dr. Paul Kubes uncovers how delayed Kupffer cell migration drives immune vulnerability in newborns. This research opens doors for neonatal care. Learn more: queensu.ca/gazette/stories/p… 🔬
New research show that NPs coronas modulate immune response via TLR4/MyD88/NF-κB under inflammatory conditions. These findings could explain therapeutics toxicity and altered efficacy. Learn more: nature.com/articles/s41467-0… 🌡️
